Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

Learn More

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

At Medicure, we are focused on improving the health of patients by offering a growing portfolio of products and services and ensuring all patients get access to care they need.

Our Products

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

April 23, 2026

MEDICURE ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF OPERATING OFFICER

April 17, 2026

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2025

November 19, 2025

More Press Releases

RMedicureDirect ^ * ) &

Medicure Inc.

Our Mission

A Heart for Life^®

At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines

Learn More
MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

A conference call will be held on Monday April 27, 2026 at 7:30 a.m. CDT, 8:30 a.m. EDT for our financial results for year ended December 31, 2025.

See Press Release
Medicure Announces Update on Enrollment in its MEND-PNPO Phase 3 Clinical Trial

There will be a presentation of the trial design and baseline data at the 2025 Child Neurology Society Conference

See Press Release
Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

Medicure's Phase 3 clinical trial aims to evaluate the use of its investigational product MC-1 for treatment of a rare pediatric disease called pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency.

Learn More
End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.

Read More
Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Medicure Inc.– via Marley Drug, creates a direct-to-consumer e-commerce pharmacy solution. The service is available in all 50 states and can fulfill a formulary of over 100 prescription medications.

Learn More

Stay Connected

Sign up for our newsletter

#PageBgImage{opacity:0}.fancybox-custom .fancybox-skin{box-shadow:0 0 50px #222}.fancybox-nav{width:60px}.fancybox-nav span{visibility:visible;opacity:1}.fancybox-nav:hover span{opacity:.7}.fancybox-next{right:-80px}.fancybox-prev{left:-80px}html{scroll-behavior:smooth}.bg-padding-top{padding-top:100px!important}.content_container_external_home_mobile.bg-padding-top,.content_container_external_mobile.bg-padding-top,.content_container_external_home_mobile .bg-padding-top,.content_container_external_mobile .bg-padding-top{padding-top:30px!important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts{height: calc(720px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_75 iframe.youtube_embed,.content_container_external .content_full .tile_size_75 iframe.youtube_embed{height: calc(860px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_75 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_75 iframe.youtube_embed.youtube_embed_shorts{height: calc(860px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_66 iframe.youtube_embed,.content_container_external .content_full .tile_size_66 iframe.youtube_embed{height: calc(780px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_66 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_66 iframe.youtube_embed.youtube_embed_shorts{height: calc(780px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_50 iframe.youtube_embed,.content_container_external .content_full .tile_size_50 iframe.youtube_embed{height: calc(550px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_50 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_50 iframe.youtube_embed.youtube_embed_shorts{height: calc(550px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_33 iframe.youtube_embed,.content_container_external .content_full .tile_size_33 iframe.youtube_embed{height: calc(360px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_33 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_33 iframe.youtube_embed.youtube_embed_shorts{height: calc(360px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_25 iframe.youtube_embed,.content_container_external .content_full .tile_size_25 iframe.youtube_embed{height: calc(237px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_25 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_25 iframe.youtube_embed.youtube_embed_shorts{height: calc(237px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_20 iframe.youtube_embed,.content_container_external .content_full .tile_size_20 iframe.youtube_embed{height: calc(224px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_20 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_20 iframe.youtube_embed.youtube_embed_shorts{height: calc(224px * 16 / 9) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts{height: calc(720px * 16 / 9) !important}#PageBgImage{opacity:0;transition:opacity 500ms;-moz-transition:opacity 500ms;-webkit-transition:opacity 500ms;-o-transition:opacity 500ms}.banner .banner_overlay .more>a{pointer-events:all}#bannerRotator ul li{-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover}#header_container,.banner{height:0}#header_container,.banner,.banner>#bannerRotator>ul>li,.banner>#bannerRotator>ul>li>img,.banner>#bannerRotator>ul>li>a>img{transition:height 500ms;-moz-transition:height 500ms;-webkit-transition:height 500ms;-o-transition:height 500ms}#content_container{margin-top:0;transition:margin 500ms;-moz-transition:margin 500ms;-webkit-transition:margin 500ms;-o-transition:margin 500ms}

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

MEDICURE ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF OPERATING OFFICER

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2025

Our Mission

A Heart for Life^®

MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

Medicure Announces Update on Enrollment in its MEND-PNPO Phase 3 Clinical Trial

There will be a presentation of the trial design and baseline data at the 2025 Child Neurology Society Conference

Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.

Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Stay Connected

Sign up for our newsletter

About

MC-1 for PNPO Deficiency

Products

Newsroom

Investors

Contact Us

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

MEDICURE ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF OPERATING OFFICER

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2025

Our Mission

A Heart for Life®

MEDICURE REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 AND SCHEDULES APRIL 27, 2026 CONFERENCE CALL

Medicure Announces Update on Enrollment in its MEND-PNPO Phase 3 Clinical Trial

There will be a presentation of the trial design and baseline data at the 2025 Child Neurology Society Conference

Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

End of an Era?Big Chain PharmaciesClose as New PlayersLike Marley Drug Step In.

Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Stay Connected

Sign up for our newsletter

About

MC-1 for PNPO Deficiency

Products

Newsroom

Investors

Contact Us

A Heart for Life^®

End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.